Where IBM Stands With Analysts
Portfolio Pulse from Benzinga Insights
IBM (NYSE:IBM) has received mixed analyst ratings over the past three months, with 7 analysts offering diverse opinions. The average 12-month price target is $152.43, with a high of $180.00 and a low of $130.00, marking a 3.73% decrease from the previous average target of $158.33. Analysts' actions include maintaining, raising, and lowering ratings and price targets. IBM's financials show a market cap above industry average, a revenue growth of 4.58%, a net margin of 11.55%, an ROE of 7.53%, but a lower-than-average ROA of 1.3% and a high debt-to-equity ratio of 2.54.
January 05, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
IBM has received a range of analyst ratings, with an average price target of $152.43, indicating a slight downward trend in expectations. The company's financials show strength in market cap, revenue growth, and net margin, but concerns exist regarding ROA and debt management.
The mixed analyst ratings and the slight decrease in the average price target suggest a neutral short-term impact on IBM's stock price. The strong financial indicators like market cap, revenue growth, and net margin could balance concerns over ROA and debt levels, leading to a neutral score. The relevance is 100 as IBM is the primary focus of the article, and the importance is set at 75 due to the significance of analyst ratings and financial performance in influencing investor decisions. The confidence level is at 90, reflecting the clear data provided but acknowledging the inherent unpredictability of market reactions.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100